Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Circle Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10959
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The company’s automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, and rapidly explore structure activity relationships. Its technology platform finds applications in a range of disease conditions including fibrosis; infection; inflammation; and indications such as cardiovascular, metabolism, neurology and pain. The company’s pipeline targets include beta-catenin, MCL1, cyclinA, cdk2 and p53. Circle Pharma is headquartered in South San Francisco, California, the US.

Circle Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circle Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Circle Pharma Raises Additional USD2 million in Series A Financing 10
Circle Pharma Raises Funds through Series A Preferred Stock Financing 11
Circle Pharma Raises USD3.8 Million in Venture Financing 12
Circle Pharma Raises Additional Funds through Seed Financing 13
Circle Pharma Raises Funds through Seed Financing 14
Partnerships 15
Circle Pharma Partners with Pfizer 15
Circle Pharma Inc – Key Competitors 16
Circle Pharma Inc – Key Employees 17
Circle Pharma Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
11/20/2017: Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer 19
01/17/2018: Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc. 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Circle Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circle Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circle Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circle Pharma Raises Additional USD2 million in Series A Financing 10
Circle Pharma Raises Funds through Series A Preferred Stock Financing 11
Circle Pharma Raises USD3.8 Million in Venture Financing 12
Circle Pharma Raises Additional Funds through Seed Financing 13
Circle Pharma Raises Funds through Seed Financing 14
Circle Pharma Partners with Pfizer 15
Circle Pharma Inc, Key Competitors 16
Circle Pharma Inc, Key Employees 17

List of Figures
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solasia Pharma KK (4597)-製薬・医療分野:企業M&A・提携分析
    Summary Solasia Pharma KK (Solasia Pharma) formerly JapanBridge Inc is a healthcare service provider that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive care products. Its products include transdermal system whi …
  • Cognition Financial Corporation:企業の戦略・SWOT・財務情報
    Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cimarex Energy Co (XEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Cimarex Energy Co (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting o …
  • IGas Energy PLC (IGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary IGas Energy PLC (IGas) is an oil and gas company that explores, develops and produces onshore oil and natural gas properties. The company extracts oil and gas trapped underground in basins. It develops and produces gas and oil reserves in the North West of England, the East Midlands, the Wea …
  • Samyang Biopharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • Aeon Global Health Corp (ADAT)-医療機器分野:企業M&A・提携分析
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory services …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BaroFold Inc-製薬・医療分野:企業M&A・提携分析
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein refolding services. The company offers services such as research study services, optimization study services, and process implementation services. Its optimization study services include confirm analytical services, res …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Companhia Energetica do Rio Grande do Norte SA (CSRN3):企業の財務・戦略的SWOT分析
    Summary Companhia Energetica do Rio Grande do Norte SA (COSERN), a subsidiary of Neoenergia SA, is an electric utility that distributes electricity. The utility offers services such as online bill payment, energy conservation, electrical safety, energy efficiency, energy audits, connect and disconne …
  • Koninklijke Philips N.V. (PHIA):電力:M&Aディール及び事業提携情報
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare soluti …
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Asia Hotel Public Company Limited:企業の戦略・SWOT・財務情報
    Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Santos Limited:企業の戦略・SWOT・財務分析
    Santos Limited - Strategy, SWOT and Corporate Finance Report Summary Santos Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Frasers Property Limited:企業の戦略・SWOT・財務情報
    Frasers Property Limited - Strategy, SWOT and Corporate Finance Report Summary Frasers Property Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆